Literature DB >> 22971095

A clinical pattern-based etiological diagnostic strategy for sensory neuronopathies: a French collaborative study.

Jean-Philippe Camdessanché1, Guillemette Jousserand, Jérôme Franques, Jean Pouget, Emilien Delmont, Alain Créange, Thierry Kuntzer, Thierry Maisonobe, Karima Abba, Jean-Christophe Antoine.   

Abstract

Sensory neuronopathies (SNNs) encompass paraneoplastic, infectious, dysimmune, toxic, inherited, and idiopathic disorders. Recently described diagnostic criteria allow SNN to be differentiated from other forms of sensory neuropathy, but there is no validated strategy based on routine clinical investigations for the etiological diagnosis of SNN. In a multicenter study, the clinical, biological, and electrophysiological characteristics of 148 patients with SNN were analyzed. Multiple correspondence analysis and logistic regression were used to identify patterns differentiating between forms of SNNs with different etiologies. Models were constructed using a study population of 88 patients and checked using a test population of 60 cases. Four patterns were identified. Pattern A, with an acute or subacute onset in the four limbs or arms, early pain, and frequently affecting males over 60 years of age, identified mainly paraneoplastic, toxic, and infectious SNN. Pattern B identified patients with progressive SNN and was divided into patterns C and D, the former corresponding to patients with inherited or slowly progressive idiopathic SNN with severe ataxia and electrophysiological abnormalities and the latter to patients with idiopathic, dysimmune, and sometimes paraneoplastic SNN with a more rapid course than in pattern C. The diagnostic strategy based on these patterns correctly identified 84/88 and 58/60 patients in the study and test populations, respectively.
© 2012 Peripheral Nerve Society.

Entities:  

Mesh:

Year:  2012        PMID: 22971095     DOI: 10.1111/j.1529-8027.2012.00411.x

Source DB:  PubMed          Journal:  J Peripher Nerv Syst        ISSN: 1085-9489            Impact factor:   3.494


  7 in total

Review 1.  Acquired neuropathies.

Authors:  Pierre Lozeron; Jean-Marc Trocello; Nathalie Kubis
Journal:  J Neurol       Date:  2013-06-16       Impact factor: 4.849

Review 2.  Subacute sensory neuronopathy associated with Merkel cell carcinoma with unknown primary: a case report with literature review.

Authors:  Riccardo Milani; Miryam Cannizzaro; Gianluigi Arrigoni; Federica Filipello; Federica Cerri; Massimo Filippi
Journal:  J Neurol       Date:  2022-04-16       Impact factor: 6.682

3.  Testing the validity of a set of diagnostic criteria for sensory neuronopathies: a francophone collaborative study.

Authors:  Jean-Christophe Antoine; Florence Robert-Varvat; Thierry Maisonobe; Alain Créange; Jérôme Franques; Stéphane Mathis; Emilien Delmont; Thierry Kuntzer; Jean-Pascal Lefaucheur; Jean Pouget; Karine Viala; Claude Desnuelle; Andoni Echaniz-Laguna; Francesco Rotolo; Jean-Philippe Camdessanché
Journal:  J Neurol       Date:  2014-08-10       Impact factor: 4.849

4.  Treatment options in paraneoplastic disorders of the peripheral nervous system.

Authors:  Jean-Christophe Antoine; Jean-Philippe Camdessanché
Journal:  Curr Treat Options Neurol       Date:  2013-04       Impact factor: 3.598

5.  Updated Diagnostic Criteria for Paraneoplastic Neurologic Syndromes.

Authors:  Francesc Graus; Alberto Vogrig; Sergio Muñiz-Castrillo; Jean-Christophe G Antoine; Virginie Desestret; Divyanshu Dubey; Bruno Giometto; Sarosh R Irani; Bastien Joubert; Frank Leypoldt; Andrew McKeon; Harald Prüss; Dimitri Psimaras; Laure Thomas; Maarten J Titulaer; Christian A Vedeler; Jan J Verschuuren; Josep Dalmau; Jerome Honnorat
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2021-05-18

6.  Pure sensory chronic inflammatory polyneuropathy: rapid deterioration after steroid treatment.

Authors:  Elisabeth Chroni; Dimitra Veltsista; Evangelia Gavanozi; Tavitha Vlachou; Panagiotis Polychronopoulos; Panagiotis Papathanasopoulos
Journal:  BMC Neurol       Date:  2015-03-11       Impact factor: 2.474

7.  A severe case of neuro-Sjögren's syndrome induced by pembrolizumab.

Authors:  Jaqueline Ghosn; Alex Vicino; Olivier Michielin; George Coukos; Thierry Kuntzer; Michel Obeid
Journal:  J Immunother Cancer       Date:  2018-10-22       Impact factor: 13.751

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.